Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment-Reference-Cited by-同舟云学术

Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment

Published:2022-08-23 Issue:9 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Hundley W. Gregory¹,D’Agostino Ralph²,Crotts Teresa³,Craver Karen⁴,Hackney Mary Helen⁵,Jordan Jennifer H.¹⁶,Ky Bonnie⁷,Wagner Lynne I.⁴,Herrington David M.³,Yeboah Joseph³,Reding Kerryn W.⁸,Ladd Amy C.¹,Rapp Stephen R.⁹,Russo Sandra¹⁰,O’Connell Nathaniel²,Weaver Kathryn E.⁴,Dressler Emily V.²,Ge Yaorong¹¹,Melin Susan A.¹²,Gudena Vinay¹³,Lesser Glenn J.¹²

Affiliation:

1. Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond

2. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC

3. Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC

4. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC

5. Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond

6. Department of Biomedical Engineering, Virginia Commonwealth University, Richmond

7. Department of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia

8. Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle

9. Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, NC

10. Division of Cancer Prevention, National Cancer Institute, Bethesda, MD

11. Department of Software and Information Systems, University of North Carolina, Charlotte

12. Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC

13. Division of Hematology and Oncology, Cone Health, Greensboro, NC

Publisher

Massachusetts Medical Society

Reference23 articles.

1. Anthracyclines and Heart Failure

2. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.

3. Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults

4. Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy

5. Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

2. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity;European Journal of Heart Failure;2024-08-30

3. Statins to prevent anthracycline-related myocardial toxicity: The jury is still out;European Journal of Internal Medicine;2024-08

4. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials;European Journal of Internal Medicine;2024-08

5. Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma;JACC: CardioOncology;2024-08